Guidant launches new pacemakers in US:
This article was originally published in Clinica
Guidant has launched its Pulsar and Pulsar Max pacemaker systems in the US. Guidant says the Pulsar devices offer a choice of sensor-based options, with either an accelerometer that measures patient movement, or a tiny ventilation sensor to measure respiration. The Pulsar provides a pacing rate that matches variations in activity levels. The Pulsar Max has an algorithm to blend the signals from two sensors to optimise pacing therapy.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.